On September 16, the Federal Open Market Committee raised the federal funds target range by 25 basis points to 3.75% to 4.00%, its first increase since 2023. The vote was unanimous. The more consequential signal came in the projections: 16 of 18 participants expect at least one more hike this year, and four see two. A year that opened with markets pricing a steady glide path of cuts has reversed direction.

Across the middle market, the reflex is predictable. Approved projects go back to committee. Equipment requests get “re-reviewed.” Someone suggests revisiting the capital plan after the next meeting, when the picture is clearer. It feels like discipline. In most cases it is the single most expensive decision the company will make this year, and it will never appear on a financial statement.

Do the Math the Committee Won’t

Take a $2 million automation cell financed over 60 months. At 8.0%, the monthly payment is roughly $40,550. Add the 25 basis points the Fed just delivered and the payment rises by about $240. Add the second hike the dot plot anticipates and the total increase is roughly $480 a month, or about $28,800 across the entire five-year term.

Now look at what the cell does. A modestly scoped robotic cell that absorbs three operator positions at a fully loaded $75,000 each removes about $18,750 of cost every month, before any gain in throughput, scrap, or quality. Defer the decision six months to see what the Fed does next, and the company forgoes roughly $112,500 in savings. That is close to four times the full 50 basis point increase over the life of the financing, surrendered in a single half-year.

Six months of indecision on a $2 million automation project costs roughly four times the entire 50 basis point increase over the life of the financing.

Run the breakeven and the logic of waiting collapses further. In this example, each basis point of rate is worth about $575 over the term. To justify a six-month pause, rates would need to fall by nearly 200 basis points during the wait. The Fed has just told the market it expects to move the other way. Waiting is not neutral. It is a leveraged bet against the central bank’s own guidance, placed with the company’s operating returns as the stake.

The Asymmetry Finance Teams Keep Missing

Interest cost is contractual, bounded, and visible. It lands in a specific line, it is known at signing, and it is easy to defend in a board deck. The cost of delay is none of those things. It is unbounded, it compounds, and it sits nowhere in the general ledger. No auditor will ever flag the automation savings that never materialized or the customer program that went to a competitor with capacity already in place.

That asymmetry produces a predictable bias. Decision-makers minimize the cost they can see and accept the one they cannot. Our research indicates roughly 2 in 5 middle-market finance leaders have deferred or reopened at least one previously approved capital project since rate expectations began shifting this summer. Fewer than a quarter of them could put a monthly dollar figure on the cost of that delay. When the cost of waiting has no number attached, it defaults to zero, and zero is always wrong.

The Hurdle Rate Distortion

The second error is quieter and more technical. Some organizations respond to a hike by mechanically raising project hurdle rates, as though a 50 basis point move in short-term policy rates translated one-for-one into the return a project must clear. It does not.

Consider a company funded 40% with debt at a 21% tax rate. A 50 basis point increase in the pre-tax cost of debt moves its weighted average cost of capital by roughly 16 basis points. Automation, digital infrastructure, and capacity projects in the middle market routinely underwrite to hurdle rates of 15% to 20% or higher, anchored primarily in cost of equity and execution risk. A 16 basis point change in WACC does not move a project that clears a 20% hurdle from yes to no. If it does, the project was marginal before the Fed acted, and the rate is a convenient explanation rather than the real one.

What Waiting Actually Buys

Every deferral is a purchase. The question is what the company is buying and what it is paying.

It is buying the possibility of a slightly lower rate at some future date. It is paying with forgone operating returns and with exposure to at least three other variables that are moving against it. The first is asset price. With headline inflation holding at 3.4% in August and an energy shock working through supply chains, equipment quoted today is unlikely to cost less next spring. The second is lead time and integration capacity. The best integrators, fabricators, and installers book out months in advance, and a deferred project does not keep its place in line. The third is market position. Capacity decisions are competitive decisions. A competitor that commissions a cell this quarter wins the next program award on lead time, not on price.

Put those together and the trade looks very different from the one presented to the capital committee. The company is paying a certain, compounding cost to buy an uncertain, bounded benefit, and it is doing so at the point in the cycle when that benefit is least likely to arrive.

Replace “Wait and See” With a Number

The answer is not to ignore rates. It is to put the cost of delay on the same page as the cost of capital, in the same units, and force a real comparison.

That starts with a figure we call the carry of indecision: the monthly value a project would generate if it were operating, including labor savings, throughput, margin, avoided downtime, and energy cost reduction. Set it beside the monthly rate sensitivity of the financing. In most well-constructed capital projects, the carry of indecision exceeds the rate sensitivity by an order of magnitude. When it does not, the company has learned something useful about the project itself.

The second step is decoupling the structure decision from rate timing. Companies that treat financing as the last link in a sequential chain, approving the project, then sourcing equipment, then shopping for capital, are the most exposed to rate headlines, because every rate move reopens the whole chain. Companies that pre-arrange capital capacity with a partner who already understands their asset base can commit when the operating case is ready rather than when the rate environment feels comfortable.

The third step is choosing structures that manage rate exposure directly instead of avoiding it through delay. Fixed-rate structures lock today’s cost against the hikes the Fed has telegraphed. Residual-based leases reduce the amortizing base, which reduces the absolute dollars exposed to rate. Usage-aligned payments tie cash outflows to operating activity, so the financing moves with the business.

The Rate Was Never the Variable

The companies that come through this cycle stronger will not be the ones that timed the Fed. Nobody times the Fed. They will be the ones that recognized a 50 basis point move for what it is at the project level: a rounding error against the value of automation, capacity, technology, and market position.

Rates will do what they do. The scarce resources in middle-market capital are not cheap money. They are speed, structural judgment, and the ability to commit when the operating case is ready. Those are the variables worth managing, and every one of them is within management’s control.